AI-empowered neurological and ocular assessment
RetinAD
State-of-the-art machine learning model for Alzheimer's risk assessment trained on proprietary dataset.
Key Benefits
accessibility
Required equipment for assessment widely available at low cost.
cost-effectiveness
Improves the yield of further clinical assessments.
social impact
Extending beyond healthcare by permitting early life planning